Home » Topics » BioWorld Science

BioWorld Science
RSS

Nanjing Legend Biotechnology describes new simian ICP47-based therapeutic cells

Dec. 14, 2021

Shanghai Longwood Biopharmaceuticals synthesizes PD-1/PD-L1 interaction inhibitors

Dec. 14, 2021

Guangzhou Fermion Technology identifies new SST4 receptor agonists

Dec. 14, 2021

Fochon Pharmaceuticals patents PI3K inhibitors

Dec. 14, 2021

Beijing Tide Pharmaceutical discloses new ATR kinase inhibitors

Dec. 14, 2021

WNK2 is differentially expressed in MYD88-mutated Waldenstrom macroglobulinemia

Dec. 14, 2021

Clonal fitness study may steer future cancer therapy

Dec. 14, 2021

Lilly and Foghorn collaborate on Foghorn's selective BRM program and additional programs

Dec. 13, 2021

Tonix and Columbia University to explore rTFF2-based therapy for gastric and colorectal cancers

Dec. 13, 2021

Q32 Bio presents preclinical data on ADX-097 from innate immunity program

Dec. 13, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Medtronic bolsters pain portfolio in $650M SPR Therapeutics buy
BioWorld
Medtronic plc is strengthening its pain management portfolio with its $650 million move to buy SPR Therapeutics Inc. and bring the company’s peripheral nerve...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
BMS-Hengrui deal strikes panic in Washington
BioWorld
On the heels of the multibillion-dollar licensing deal between Bristol Myers Squibb Co. and Jiangsu Hengrui Pharmaceuticals Co. Ltd., Chairman John Moolenaar...